Study of SANTYL® vs Hydrogel (SoloSite®) for Pressure Ulcers
Stopped early · Phase 4
Conditions studied: Pressure Ulcer
In brief
This study is designed to compare SANTYL® versus hydrogel (SoloSite®) in the treatment of pressure ulcers for participants in a long-term care facility. After meeting study criteria, participants will be randomly assigned for application of SANTYL® or SoloSite® to their pressure ulcer for up to 6 weeks. A study previously conducted showed that in the long-term care setting, the removal of dead skin (debridement) with SANTYL® resulted in more participants achieving complete debridement, more rapidly than when SoloSite® is used. The goal of the present study is to confirm the results of the earlier study, demonstrating superior debridement outcomes for pressure ulcers of patients in long-term care as compared to ulcers managed with SoloSite®.
Key facts
- Study ID
- NCT02718625
- Run by
- Smith & Nephew, Inc.
- People needed
- 3
- Starts
- 2016-08-01
- Expected to finish
- 2017-03-09
- Last updated by the study team
- 2020-03-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Study site — Lee's Summit, Missouri, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.